JP2001316293A5 - - Google Patents

Download PDF

Info

Publication number
JP2001316293A5
JP2001316293A5 JP2001047695A JP2001047695A JP2001316293A5 JP 2001316293 A5 JP2001316293 A5 JP 2001316293A5 JP 2001047695 A JP2001047695 A JP 2001047695A JP 2001047695 A JP2001047695 A JP 2001047695A JP 2001316293 A5 JP2001316293 A5 JP 2001316293A5
Authority
JP
Japan
Prior art keywords
medicament according
glucosidase inhibitor
mitiglinide
repaglinide
insulin secretagogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001047695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001316293A (ja
JP4917712B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001047695A priority Critical patent/JP4917712B2/ja
Priority claimed from JP2001047695A external-priority patent/JP4917712B2/ja
Publication of JP2001316293A publication Critical patent/JP2001316293A/ja
Publication of JP2001316293A5 publication Critical patent/JP2001316293A5/ja
Application granted granted Critical
Publication of JP4917712B2 publication Critical patent/JP4917712B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001047695A 2000-02-24 2001-02-23 併用医薬 Expired - Lifetime JP4917712B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001047695A JP4917712B2 (ja) 2000-02-24 2001-02-23 併用医薬

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000052297 2000-02-24
JP2000052297 2000-02-24
JP2000-52297 2000-02-24
JP2001047695A JP4917712B2 (ja) 2000-02-24 2001-02-23 併用医薬

Publications (3)

Publication Number Publication Date
JP2001316293A JP2001316293A (ja) 2001-11-13
JP2001316293A5 true JP2001316293A5 (zh) 2007-08-16
JP4917712B2 JP4917712B2 (ja) 2012-04-18

Family

ID=26586285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001047695A Expired - Lifetime JP4917712B2 (ja) 2000-02-24 2001-02-23 併用医薬

Country Status (1)

Country Link
JP (1) JP4917712B2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2490250A1 (en) * 2002-06-28 2004-01-08 Kissei Pharmaceutical Co., Ltd. Drug composition for blood sugar control
US20050215607A1 (en) * 2002-06-28 2005-09-29 Imao Mikoshiba Drug composition for prevention or inhibition of advance of diabetic complication
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
EP1714648A4 (en) * 2004-02-09 2010-05-26 Aska Pharm Co Ltd COMBINATION DRUGS
CA2605302A1 (en) * 2005-04-20 2006-11-02 Kissei Pharmaceutical Co., Ltd. Combined pharmaceutical preparation for treatment of type 2 diabetes
JP5678477B2 (ja) 2009-05-28 2015-03-04 旭硝子株式会社 光学ガラス

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715298D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
JPH11130696A (ja) * 1997-08-27 1999-05-18 Takeda Chem Ind Ltd 経口徐放性製剤

Similar Documents

Publication Publication Date Title
NO20014519D0 (no) Apomorfin- og sildenafilpreparat
BRPI0519471A2 (pt) formulaÇço complexa de liberaÇço controlada para administraÇço oral de medicamentos para diabÉticos e mÉtodo para o seu preparo
CA2434484A1 (en) Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
RU2008119454A (ru) Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом
JP2002528502A5 (zh)
NZ613291A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
WO2000041504A3 (en) Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
JP2004537500A5 (zh)
CA2401000A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
JP2003514025A5 (zh)
JP2001316293A5 (zh)
JP2005508963A5 (zh)
JP2002540148A5 (zh)
JP2002530353A5 (zh)
IL163091A (en) Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction
CA2396209A1 (en) The use of mirtazapine for the treatment of sleep disorders
LT2006024A (en) Tetrapeptide regulating blood glucose level in diabetes mellitus
JP2005513105A5 (zh)
JP2002523362A5 (zh)
CA2515259A1 (en) Use of acetylsalicylic acid for the treatment of hemorrhoidal disease
RU2004121780A (ru) Способ лечения